Down-regulation of β-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: A proteomic study

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 2, 2008, Pages 179-186

  Weng, Yong Qiang ^a   Qiu, Shuang Jian ^a   Liu, Yin Kun ^a   Fan, Jia ^a   Gao, Qiang ^a   Tang, Zhao You ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

centractin; Dendritic cells (DCs); Hepatocellular carcinoma (HCC); Proteomics

Indexed keywords

BETA CENTRACTIN; CD86 ANTIGEN; GENE PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CELL LYSATE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LIVER CELL CARCINOMA; METASTASIS; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

ACTINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; LIVER NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 36849012495     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0267-0     Document Type: Article

References (48)

1. Al-Alwan MM, Rowden G, Lee TD, West KA (2001) The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J Immunol 166:1452-1456
2. Al-Alwan MM, Liwski RS, Haeryfar SM, Baldridge WH, Hoskin DW, Rowden G, West KA (2003) Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent. J Immunol 171:4479-4483
3. Aspengren S, Wallin M (2004) A role for spectrin in dynactin-dependent melanosome transport in xenopus laevis melanophores. Pigment Cell Res 17:295-301
4. Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME, Smyth MJ, Degli-Esposti MA (2005) Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 42:547-555
5. Bingham JB, Schroer TA (1999) Self-regulated polymerization of the actin-related protein Arp1. Curr Biol 9:223-226
6. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML (2001) The immunological synapse. Annu Rev Immunol 19:375-396
7. Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR (2004) Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 10:7260-7269
8. Bohnenkamp HR, Coleman J, Burchell JM, Taylor-Papadimitriou J, Noll T (2004) Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers. Cell Immunol 231:112-125
9. Creusot RJ, Mitchison NA, Terazzini NM (2002) The immunological synapse. Mol Immunol 38:997-1002
10. Clark SW, Meyer DI (1992) Centractin is an actin homologue associated with the centrosome. Nature 359:246-250
11. Clark SW, Staub O, Clark IB, Holzbaur EL, Paschal BM, Vallee RB, Meyer DI (1994) Beta-centractin: characterization and distribution of a new member of the centractin family of actin-related proteins. Mol Biol Cell 5:1301-1310
12. Clark IB, Meyer DI (1999) Overexpression of normal and mutant Arp1alpha (centractin) differentially affects microtubule organization during mitosis and interphase. J Cell Sci 112:3507-3518
13. Cuadrado-Tejedor M, Sesma MT, Gimenez-Amaya JM, Ortiz L (2005) Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice. Neurobiol Dis 20:666-672
14. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148
15. Dustin ML, Tseng SY, Varma R, Campi G (2006) T cell-dendritic cell immunological synapses. Curr Opin Immunol 18:512-516
16. Elsea SH, Clark IB, Juyal RC, Meyer DJ, Meyer DI, Patel PI (1999) Assignment of beta-centractin (CTRN2) to human chromosome 2 bands q11.1->q11.2 with somatic cell hybrids and in situ hybridization. Cytogenet Cell Genet 84:48-49
17. Eaton BA, Fetter RD, Davis GW (2002) Dynactin is necessary for synapse stabilization. Neuron 34:729-741
18. Friedman KM, Fox BA (2004) The promising future of proteomics in cancer diagnosis and treatment. Eur J Gastroenterol Hepatol 17:701-703
19. Feng JT, Shang S, Beretta L (2006) Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene 25:3810-3817
20. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML (1999) The immunological synapse: a molecular machine controlling T cell activation. Science 285:221-227
21. Gregoire M, Ligeza-Poisson C, Juge-Morineau N, Spisek R (2003) Anti-cancer therapy using dendritic cells and apoptotic tumour cells: pre-clinical data in human mesothelioma and acute myeloid leukaemia. Vaccine 21:791-794
22. Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4:941-952
23. Holleran EA, Tokito MK, Karki S, Holzbaur EL (1996) Centractin (ARP1) associates with spectrin revealing a potential mechanism to link dynactin to intracellular organelles. J Cell Biol 135:1815-1829
24. Kiertscher SM, Luo J, Dubinett SM, Roth MD (2000) Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 164:1269-1276
25. Kotera Y, Shimizu K, Mule JJ (2001) Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res 61:8105-8109
26. Lees-Miller JP, Helfman DM, Schroer TA (1992) A vertebrate actin-related protein is a component of a multisubunit complex involved in microtubule-based vesicle motility. Nature 359:244-246
27. Lanzavecchia A, Sallusto F (2001) Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2:487-492
28. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630-636
29. Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL, Liu YK, Tang ZY (2004) Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 130:460-468
30. Li MS, Ma QL, Chen Q, Liu XH, Li PF, Du GG, Li G (2005) Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells. World J Gastroenterol 11:2564-2569
31. Nagao M, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Ko S, Tatekawa Y, Ikeda N, Kanokogi H, Urizono Y, Kobayashi T, Shibaji T, Kanamura T, Ogawa S, Nakano H (2000) The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma. Hepatology 32:491-500
32. Plamann M, Minke PF, Tinsley JH, Bruno KS (1994) Cytoplasmic dynein and actin-related protein Arp1 are required for normal nuclear distribution in filamentous fungi. J Cell Biol 127:139-149
33. Pardoll DM (2002) Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2:227-238
34. Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC (2005) Proteomic analysis for the early detection and rational treatment of cancer-realistic hope? Ann Oncol 16:16-22
35. Pereira SR, Faca VM, Gomes GG, Chammas R, Fontes AM, Covas DT, Greene LJ (2005) Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics 5:1186-1198
36. Pizzo P, Viola A (2005) Lipid-based membrane microdomains in T cell activation. Curr Immunol Rev 1:7-12
37. Richards J, Le, Naour F, Hanash S, Beretta L (2002) Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann NY Acad Sci 975:91-100
38. Schroer TA (1994) New insights into the interaction of cytoplasmic dynein with the actin-related protein, Arp 1. J Cell Biol 127:1-4
39. Schafer DA, Gill SR, Cooper JA, Heuse JE, Schroer TA (1994) Ultrastructural analysis of the dynactin complex:an actin-related protein is a component of a filament that resembles F-actin. J Cell Biol 126:403-412
40. Steinman RM, Turley S, Mellman I, Inaba K (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411-416
41. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358
42. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eigler A (2001) Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res 61:6445-6450
43. Seliger B, Maeurer MJ, Ferrone S (2000) Antigen-processing machinery breakdown and tumor growth. Immunol Today 21:455-464
44. Slingluff CL Jr, Engelhard VH, Ferrone S (2000) Peptide and dendritic cell vaccines. Clin Cancer Res 12:2342s-2345s
45. Srivastava PK (2000) Immunotherapy of human cancer: lessons from mice. Nat Immunol 1:363-366
46. Um SH, Mulhall C, Alisa A, Ives AR, Karani J, Williams R, Bertoletti A, Behboudi S (2004) Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol 1731:1772-1778
47. Vallee RB, Sheetz MP (1996) Targeting of motor proteins. Science 271:1539-1544
48. Way M, Weeds A (1990) Actin-binding proteins. Cytoskeletal ups and downs. Nature 344:292-294